SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-012929
Filing Date
2024-09-20
Accepted
2024-09-20 16:30:26
Documents
59
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pxmd-20240630x10q.htm   iXBRL 10-Q 998498
2 EX-31.1 pxmd-20240630xex31d1.htm EX-31.1 13768
3 EX-31.2 pxmd-20240630xex31d2.htm EX-31.2 15813
4 EX-32.1 pxmd-20240630xex32d1.htm EX-32.1 6848
5 EX-32.2 pxmd-20240630xex32d2.htm EX-32.2 6882
  Complete submission text file 0001558370-24-012929.txt   4258627

Data Files

Seq Description Document Type Size
6 EX-101.SCH pxmd-20240630.xsd EX-101.SCH 37334
7 EX-101.CAL pxmd-20240630_cal.xml EX-101.CAL 24359
8 EX-101.DEF pxmd-20240630_def.xml EX-101.DEF 148608
9 EX-101.LAB pxmd-20240630_lab.xml EX-101.LAB 298936
10 EX-101.PRE pxmd-20240630_pre.xml EX-101.PRE 236748
62 EXTRACTED XBRL INSTANCE DOCUMENT pxmd-20240630x10q_htm.xml XML 503827
Mailing Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591
Business Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591 914-987-2876
PaxMedica, Inc. (Filer) CIK: 0001811623 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41475 | Film No.: 241313760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)